Fecal Calprotectin Interpreter
Distinguish between IBS and IBD using fecal calprotectin levels. Non-invasive biomarker for intestinal inflammation to guide endoscopy decisions and monitor disease activity.
Enter the lab result in micrograms per gram
Reference ranges may vary by age
Interpretation Guide
| Level (mcg/g) | Interpretation | Likelihood of IBD | Action |
|---|---|---|---|
| < 50 | Normal | Very low (<1%) | Consider IBS; avoid endoscopy unless alarm features |
| 50-99 | Borderline Low | Low (5-10%) | Clinical judgment; repeat in 4-6 weeks if uncertain |
| 100-199 | Borderline Elevated | Moderate (20-40%) | Rule out infection; consider endoscopy if persistent |
| 200-499 | Elevated | High (60-80%) | Endoscopy recommended; check for infections |
| ≥ 500 | Markedly Elevated | Very high (>90%) | Urgent endoscopy; GI consultation |
< 50 mcg/g: Excellent negative predictive value (NPV) >95% for excluding IBD. Safe to treat as functional disorder without endoscopy in most cases.
50-200 mcg/g: Gray zone requiring clinical judgment. Consider patient age, symptom duration, alarm features, family history, and NSAID use when deciding on endoscopy.
> 200 mcg/g: Strong indication for endoscopy. Positive predictive value increases with higher levels. In known IBD, indicates active disease and need for treatment adjustment.
About Fecal Calprotectin
Fecal calprotectin is a calcium-binding protein released by neutrophils during intestinal inflammation. It is a highly sensitive and specific biomarker for distinguishing inflammatory bowel disease (IBD) from irritable bowel syndrome (IBS) and other functional GI disorders.
Clinical Applications
- Differentiating IBD from IBS in patients with chronic GI symptoms
- Guiding decisions about endoscopy - avoiding unnecessary procedures
- Monitoring disease activity in known IBD patients
- Assessing response to treatment and predicting relapse
- Detecting subclinical inflammation in asymptomatic IBD patients
Advantages
- Non-invasive stool test - no bowel preparation needed
- High sensitivity (90-95%) and specificity (85-95%) for IBD
- Cost-effective screening tool to reduce unnecessary colonoscopies
- Results correlate well with endoscopic disease activity
- Can be repeated easily for monitoring
- Stable in stool at room temperature for several days
Factors That Can Elevate Calprotectin
- IBD: Crohn's disease, ulcerative colitis
- Infections: Bacterial, viral, or parasitic gastroenteritis
- Medications: NSAIDs, aspirin, proton pump inhibitors
- Other GI conditions: Microscopic colitis, diverticulitis, colorectal cancer
- Age: Infants and young children may have higher baseline levels
- Recent diarrhea: May cause transient elevation
Monitoring Disease Activity
In patients with established IBD, fecal calprotectin correlates with endoscopic inflammation and can predict relapse. Levels typically decrease with effective treatment. Rising levels in patients in remission may indicate impending flare, allowing for early intervention.
Frequently Asked Questions
How is the fecal calprotectin test performed?
A small stool sample is collected at home using a collection kit provided by your healthcare provider or lab. No special diet or bowel preparation is required. The sample is stable at room temperature for several days and can be mailed to the lab. Results typically available in 2-5 days.
Can I take this test if I have diarrhea?
Yes, the test works with formed or loose stools. However, acute diarrhea from any cause (including viral gastroenteritis) can temporarily elevate calprotectin. If you have acute symptoms, it may be better to wait until symptoms stabilize or interpret results cautiously.
Should I stop medications before testing?
Do not stop IBD medications (immunosuppressants, biologics, 5-ASA). However, NSAIDs and aspirin can cause intestinal inflammation and elevate calprotectin. If possible, avoid these for 1-2 weeks before testing, but only if medically safe to do so. Inform your provider about all medications.
What if my level is borderline (50-200)?
Borderline results require clinical judgment. Consider repeating the test in 4-6 weeks if symptoms persist. Rule out recent infections or NSAID use. If alarm features are present (bleeding, weight loss, anemia, family history of IBD), endoscopy may still be warranted.
Can calprotectin distinguish between Crohn's and ulcerative colitis?
No. Calprotectin indicates the presence of intestinal inflammation but cannot differentiate between Crohn's disease and ulcerative colitis. Endoscopy with biopsies is required for specific diagnosis. However, Crohn's disease may sometimes show higher levels.
How often should I test if I have IBD?
Monitoring frequency depends on disease activity and treatment. During active disease or after treatment changes, testing every 2-3 months may be appropriate. In stable remission, every 6-12 months is often sufficient. Your gastroenterologist will guide the monitoring schedule.
Can the test be normal even if I have IBD?
Yes, but rarely. False negatives can occur with very localized disease, isolated upper GI Crohn's, or inactive disease. If clinical suspicion for IBD is high despite normal calprotectin, endoscopy may still be warranted. The test is most accurate for colonic inflammation.
Are there age-specific reference ranges?
Yes. Infants and young children (especially <4 years) can have higher baseline levels. Some labs use a cutoff of <250 mcg/g for children. For adults, <50 mcg/g is universally considered normal. Always interpret results with the lab's specific reference ranges.
Related Calculators
Fat-Soluble Vitamin Calculator
Vitamin supplementation for IBD and malabsorption
Iron Calculator
Assess iron status in IBD patients
Glasgow-Blatchford Score
GI bleeding risk assessment
Child-Pugh Calculator
Liver disease severity in IBD with PSC
Vitamin D Dosage Calculator
Vitamin D supplementation for IBD
Anemia Calculator
Diagnose anemia in IBD patients